XML 21 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 7 - Note Payable (Details) (USD $)
12 Months Ended 0 Months Ended 12 Months Ended 28 Months Ended 12 Months Ended 1 Months Ended 0 Months Ended 1 Months Ended 7 Months Ended 11 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Jun. 27, 2012
Dec. 31, 2013
Warrant [Member]
Dec. 31, 2013
Closing Price Per Share [Member]
Nov. 25, 2013
Warrant [Member]
Nov. 25, 2013
Hercules [Member]
Hercules Credit Agreement [Member]
Nov. 25, 2013
Oxford and Horizon [Member]
Dec. 31, 2013
November 2011 Capital Lease [Member]
Feb. 28, 2014
November 2011 Capital Lease [Member]
Nov. 30, 2011
November 2011 Capital Lease [Member]
Dec. 31, 2013
October 2009 Capital Lease [Member]
Dec. 31, 2013
Contract Termination [Member]
Oxford and Horizon Credit Agreement [Member]
Nov. 25, 2013
Hercules Credit Agreement [Member]
Dec. 31, 2013
Hercules Credit Agreement [Member]
Nov. 30, 2013
Hercules Credit Agreement [Member]
Dec. 31, 2012
Oxford and Horizon Credit Agreement [Member]
Nov. 30, 2013
Oxford and Horizon Credit Agreement [Member]
Jun. 27, 2013
Term A Loan [Member]
Dec. 31, 2013
Credit Agreement [Member]
Nov. 25, 2013
Warrant [Member]
Hercules [Member]
Hercules Credit Agreement [Member]
Note 7 - Note Payable (Details) [Line Items]                                          
Line of Credit Facility, Maximum Borrowing Capacity     $ 10,000,000       $ 20,000,000                            
Loan Tranche Amount     5,000,000       5,000,000                            
Repayments of Lines of Credit               4,000,000                          
Line of Credit Facility, Remaining Borrowing Capacity             15,000,000                            
Debt Instrument, Basis Spread on Variable Rate             11.25%                            
Debt Conversion, Converted Instrument, Warrants or Options Issued (in Shares) 11,415           194,986                            
Common Stock, Par or Stated Value Per Share (in Dollars per share) $ 0.01 $ 0.01     $ 2.80                           $ 2.92   $ 3.59
Deferred Finance Costs, Net 217,715     73,654   521,763               352,378              
Fair Value Assumptions, Expected Volatility Rate   92.02%                       102.00%           74.30%  
Fair Value Assumptions, Risk Free Interest Rate   0.73%                       1.37%           1.10%  
Fair Value Assumptions, Expected Term   1 year 47 days                       5 years           3 years 6 months  
Fair Value Assumptions, Exercise Price (in Dollars per share)                           $ 3.55              
Amortization of Deferred Charges                             57,813            
Interest Expense, Debt                             29,892   300,278 572,264      
Repayments of Debt and Capital Lease Obligations                         4,100,000                
Proceeds from Issuance of Debt                               4,000,000          
Amortization of Financing Costs                                 43,215 248,160      
Debt Instrument, Interest Rate, Stated Percentage 11.75%                                        
Note Stock Conversion Rate 3.00%                                        
Warrants Issued Expiration Period 7 years                                        
Capital Leased Assets, Gross                     144,448                    
Debt Instrument, Periodic Payment                 10,891 5,651                      
Payments for (Proceeds from) Loans and Leases                       $ 67,817